Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
01 2021
Historique:
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 18 5 2021
Statut: epublish

Résumé

The possibility that onchocerciasis may cause epilepsy has been suggested for a long time, but thus far, an etiological link has not been universally accepted. The objective of this review is to critically appraise the relationship between Onchocerca volvulus and epilepsy and subsequently apply the Bradford Hill criteria to further evaluate the likelihood of a causal association. PubMed and gray literature published until September 15, 2020, were searched and findings from original research were synthesized. Adherence to the 9 Bradford Hill criteria in the context of onchocerciasis and epilepsy was determined to assess whether the criteria are met to strengthen the evidence base for a causal link between infection with O. volvulus and epilepsy, including the nodding syndrome. Onchocerciasis as a risk factor for epilepsy meets the following Bradford Hill criteria for causality: strength of the association, consistency, temporality, and biological gradient. There is weaker evidence supporting causality based on the specificity, plausibility, coherence, and analogy criteria. There is little experimental evidence. Considering the Bradford Hill criteria, available data suggest that under certain conditions (high microfilarial load, timing of infection, and perhaps genetic predisposition), onchocerciasis is likely to cause epilepsy including nodding and Nakalanga syndromes. Applying the Bradford Hill criteria suggests consistent epidemiological evidence that O. volvulus infection is a trigger of epilepsy. However, the pathophysiological mechanisms responsible for seizure induction still need to be elucidated.

Sections du résumé

BACKGROUND
The possibility that onchocerciasis may cause epilepsy has been suggested for a long time, but thus far, an etiological link has not been universally accepted. The objective of this review is to critically appraise the relationship between Onchocerca volvulus and epilepsy and subsequently apply the Bradford Hill criteria to further evaluate the likelihood of a causal association.
METHODS
PubMed and gray literature published until September 15, 2020, were searched and findings from original research were synthesized. Adherence to the 9 Bradford Hill criteria in the context of onchocerciasis and epilepsy was determined to assess whether the criteria are met to strengthen the evidence base for a causal link between infection with O. volvulus and epilepsy, including the nodding syndrome.
RESULTS
Onchocerciasis as a risk factor for epilepsy meets the following Bradford Hill criteria for causality: strength of the association, consistency, temporality, and biological gradient. There is weaker evidence supporting causality based on the specificity, plausibility, coherence, and analogy criteria. There is little experimental evidence. Considering the Bradford Hill criteria, available data suggest that under certain conditions (high microfilarial load, timing of infection, and perhaps genetic predisposition), onchocerciasis is likely to cause epilepsy including nodding and Nakalanga syndromes.
CONCLUSION
Applying the Bradford Hill criteria suggests consistent epidemiological evidence that O. volvulus infection is a trigger of epilepsy. However, the pathophysiological mechanisms responsible for seizure induction still need to be elucidated.

Identifiants

pubmed: 33411705
doi: 10.1371/journal.pntd.0008965
pii: PNTD-D-20-00030
pmc: PMC7790236
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008965

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2009 Jun 16;3(6):e461
pubmed: 19529767
Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):537-41
pubmed: 12474484
Pan Afr Med J. 2015 May 13;21:29
pubmed: 26401223
Epilepsy Res. 1998 May;30(3):247-51
pubmed: 9657652
Int J Occup Environ Health. 2004 Apr-Jun;10(2):233-9
pubmed: 15281385
Lancet. 1994 Jan 15;343(8890):183-4
pubmed: 7904037
Epileptic Disord. 2019 Oct 1;21(5):425-435
pubmed: 31649005
Brain Res Bull. 2019 Feb;145:45-52
pubmed: 30468846
Emerg Themes Epidemiol. 2015 Sep 30;12:14
pubmed: 26425136
Trop Med Int Health. 1999 May;4(5):322-34
pubmed: 10402967
Int J Infect Dis. 2016 Aug;49:1-8
pubmed: 27210267
Circulation. 2012 Apr 10;125(14):1718-20
pubmed: 22412071
Afr Health Sci. 2013 Jun;13(2):183-204
pubmed: 24235915
Am J Trop Med Hyg. 2015 Jul;93(1):198-202
pubmed: 25918208
Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:13-7
pubmed: 18718148
Infect Dis Poverty. 2018 Nov 14;7(1):112
pubmed: 30424817
Lancet. 1983 Feb 12;1(8320):358
pubmed: 6130361
J Neural Transm (Vienna). 2014 Aug;121(8):1029-75
pubmed: 25081016
Lancet. 1996 Mar 23;347(9004):836
pubmed: 8622372
Int J Environ Health Res. 2004 Oct;14(5):359-69
pubmed: 15385215
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
J Neurol Sci. 2016 Oct 15;369:191-203
pubmed: 27653888
Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):525-7
pubmed: 9463656
MMWR Morb Mortal Wkly Rep. 2012 Jan 27;61(3):52-4
pubmed: 22278159
J Alzheimers Dis. 2017;60(1):183-200
pubmed: 28826180
Am J Trop Med Hyg. 2008 Nov;79(5):643-4; author reply 644-5
pubmed: 18981494
Pathogens. 2020 Mar 10;9(3):
pubmed: 32164367
Trans R Soc Trop Med Hyg. 2007 Jan;101(1):48-55
pubmed: 16905166
Trop Med Parasitol. 1989 Sep;40(3):340-7
pubmed: 2617045
PLoS Negl Trop Dis. 2020 Jul 8;14(7):e0008436
pubmed: 32639997
Afr Health Sci. 2018 Sep;18(3):837-841
pubmed: 30603018
Br J Ophthalmol. 1962 Jan;46(1):1-11
pubmed: 18170747
Acta Neuropathol. 2018 Nov;136(5):691-697
pubmed: 30219940
Infect Dis Poverty. 2018 Mar 28;7(1):21
pubmed: 29587844
Epilepsia. 2003 Jul;44(7):956-63
pubmed: 12823580
Emerg Infect Dis. 2013;19(9):1374-84
pubmed: 23965548
Pan Afr Med J. 2017 Sep 04;28:1
pubmed: 29138647
Epilepsy Behav. 2019 Jan;90:70-78
pubmed: 30513438
Lancet. 2004 May 8;363(9420):1514-21
pubmed: 15135599
PLoS Negl Trop Dis. 2017 Jul 14;11(7):e0005732
pubmed: 28708828
Trends Parasitol. 2018 Mar;34(3):208-216
pubmed: 29288080
Epilepsy Res. 2008 Dec;82(2-3):200-10
pubmed: 18976884
PLoS One. 2013 Jun 18;8(6):e66419
pubmed: 23823012
Seizure. 2018 Nov;62:108-115
pubmed: 30340162
Lancet Infect Dis. 2020 Nov;20(11):1223-1224
pubmed: 32598870
Trends Parasitol. 2016 Dec;32(12):966-978
pubmed: 27665524
Lancet Neurol. 2013 Mar;12(3):253-63
pubmed: 23375964
Epileptic Disord. 2020 Jun 1;22(3):301-308
pubmed: 32540799
Am J Trop Med Hyg. 1996 Jan;54(1):80-3
pubmed: 8651377
Infect Dis Poverty. 2019 Jan 23;8(1):8
pubmed: 30670093
J Infect Dis. 1997 Nov;176(5):1334-43
pubmed: 9359736
Infect Dis Poverty. 2018 Aug 1;7(1):68
pubmed: 30064504
PLoS Negl Trop Dis. 2013;7(3):e2147
pubmed: 23556028
Afr Health Sci. 2013 Jun;13(2):529-40
pubmed: 24235964
Pathogens. 2020 Mar 05;9(3):
pubmed: 32151038
JMIR Res Protoc. 2017 Aug 30;6(8):e137
pubmed: 28855148
Lancet Infect Dis. 2018 Nov;18(11):1278-1286
pubmed: 30268645
Am J Epidemiol. 1999 Mar 15;149(6):565-70
pubmed: 10084246
Am J Trop Med Hyg. 2012 Mar;86(3):557
pubmed: 22403337
EMBO Mol Med. 2016 Mar 31;8(4):305-7
pubmed: 26976611
Sci Transl Med. 2017 Feb 15;9(377):
pubmed: 28202777
Ann Trop Med Parasitol. 2001 Jun;95(4):379-88
pubmed: 11454247
PLoS Negl Trop Dis. 2012;6(3):e1578
pubmed: 22479660
Trends Parasitol. 2017 Jul;33(7):490
pubmed: 28596063
Acta Neurol Scand. 1995 Jul;92(1):33-40
pubmed: 7572058
Public Health. 2006 May;120(5):448-50
pubmed: 16524608
BMC Res Notes. 2016 Mar 22;9:182
pubmed: 27005304
Stat Med. 2016 May 20;35(11):1749-62
pubmed: 26646432
BMC Neurol. 2019 Mar 6;19(1):35
pubmed: 30841858
Trop Med Int Health. 2001 Sep;6(9):715-25
pubmed: 11555439
PLoS Genet. 2018 Nov 16;14(11):e1007755
pubmed: 30444878
PLoS Negl Trop Dis. 2016 May 03;10(5):e0004478
pubmed: 27139245
Int J Infect Dis. 2019 Feb;79:187-194
pubmed: 30711145
Bull World Health Organ. 2005 Oct;83(10):792-5
pubmed: 16283057
Compr Psychiatry. 2019 Aug;93:14-19
pubmed: 31280142
Infect Dis Poverty. 2018 Oct 8;7(1):79
pubmed: 30293530
Am J Trop Med Hyg. 2008 Mar;78(3):400-1
pubmed: 18337333
Int J Infect Dis. 2020 Feb;91:119-123
pubmed: 31786246
Brain. 2016 Sep;139(Pt 9):2441-55
pubmed: 27497924
J Autoimmun. 2020 Aug;112:102462
pubmed: 32561150
Lancet. 1998 May 2;351(9112):1341-6
pubmed: 9643811
Am J Trop Med Hyg. 2011 Aug;85(2):225-8
pubmed: 21813839
Parasit Vectors. 2015 Feb 08;8:89
pubmed: 25884672
Open Forum Infect Dis. 2020 Jun 02;7(6):ofaa206
pubmed: 32587878
Infect Dis Poverty. 2018 Dec 3;7(1):114
pubmed: 30501640
Med Trop (Mars). 2000;60(2):151-5
pubmed: 11100441
Parasitology. 2010 Sep;137(10):1559-68
pubmed: 20388236
J Neuropathol Exp Neurol. 2019 Nov 1;78(11):1049-1058
pubmed: 31553445
Neuroepidemiology. 2004 May-Jun;23(3):144-9
pubmed: 15084784
Parasitology. 1998 Apr;116 ( Pt 4):349-62
pubmed: 9585937
Nat Neurosci. 2016 Aug;19(8):1085-92
pubmed: 27322420
Filaria J. 2003 Oct 24;2 Suppl 1:S7
pubmed: 14975064
East Afr Med J. 1992 Oct;69(10):554-6
pubmed: 1473507
Bull World Health Organ. 1996;74(4):361-7
pubmed: 8823957
Trends Parasitol. 2016 Aug;32(8):581-583
pubmed: 27289272
Ann Trop Med Parasitol. 1987 Jun;81(3):253-62
pubmed: 3662667
Afr Health Sci. 2012 Sep;12(3):242-8
pubmed: 23382736
Microbes Infect. 2004 Jan;6(1):113-28
pubmed: 14738900
Int J Infect Dis. 2019 May;82:77-78
pubmed: 30885705
PLoS Negl Trop Dis. 2019 Jul 17;13(7):e0007300
pubmed: 31314757
Annu Rev Pathol. 2020 Jan 24;15:395-417
pubmed: 31977293
Lancet Neurol. 2013 Feb;12(2):166-74
pubmed: 23305742
Seizure. 2018 Dec;63:93-101
pubmed: 30468964
Parasit Vectors. 2019 Mar 19;12(1):114
pubmed: 30890155
Trans R Soc Trop Med Hyg. 1963 Jan;57:71-5
pubmed: 14016593
Infect Dis Poverty. 2020 Mar 2;9(1):12
pubmed: 32114979
Pathogens. 2020 Apr 24;9(4):
pubmed: 32344586
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1089-99
pubmed: 7510272
PLoS Negl Trop Dis. 2017 Feb 9;11(2):e0005201
pubmed: 28182652
Infect Dis Poverty. 2018 Jun 20;7(1):64
pubmed: 29921319
Tropenmed Parasitol. 1976 Jun;27(2):123-32
pubmed: 941247
PLoS Negl Trop Dis. 2014 May 29;8(5):e2908
pubmed: 24875312
Int Health. 2020 May 1;12(3):192-202
pubmed: 32141502

Auteurs

Robert Colebunders (R)

Global Health Institute, University of Antwerp, Antwerp, Belgium.

Alfred K Njamnshi (AK)

Neurology Department, Yaoundé Central Hospital, Yaoundé, Cameroon.
Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé Cameroon.
Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.

Sonia Menon (S)

Global Health Institute, University of Antwerp, Antwerp, Belgium.

Charles R Newton (CR)

Department of Psychiatry, University of Oxford, Oxford, United Kingdom.

An Hotterbeekx (A)

Global Health Institute, University of Antwerp, Antwerp, Belgium.

Pierre-Marie Preux (PM)

Institute of Epidemiology and Tropical Neurology, INSERM UMR1094, University of Limoges, Limoges, France.

Adrian Hopkins (A)

Neglected and Disabling Diseases of Poverty Consultant, Kent, United Kingdom.

Michel Vaillant (M)

Competence Center in Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg.

Joseph Nelson Siewe Fodjo (JN)

Global Health Institute, University of Antwerp, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH